Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Beroni announced its development of a medical solution using nanobody technology for the novel coronavirus in collaboration with Tianjin University has advanced into cytological experiments.
read more
Wednesday, October 07, 2020
BIAL and Recipharm, have expanded a long-term agreement for the global manufacturing and supply of BIAL’s proprietary molecule opicapone.
read more
Thursday, December 14, 2017
BioVectra announced a long-term supply agreement with Keryx Biopharmaceuticals to manufacture Ferric Citrate.
read more
Tuesday, October 31, 2017
Boehringer Ingelheim and Sarah Cannon Research Institute announced an expansion of their partnership to develop novel immuno-oncology therapies
read more
Wednesday, February 11, 2015
Boehringer Ingelheim, a research-based, global pharmaceutical company, and VTU Technology, a leading contract research and development company, announced today the renewal of their global Pichia pastoris technology collaboration agreement. VTU ...
read more
Boehringer Ingelheim and Eli Lilly announced a research collaboration with DCRI for the prevention of Chronic heart failure and mortality after an acute Myocardial Infarction.
read more
Thursday, November 16, 2017
Boehringer Ingelheim and MiNA have signed a collaboration and licensing agreement focused on the development of novel compounds to treat fibrotic liver diseases.
read more
Wednesday, March 17, 2021
Bryant Ranch Prepack is voluntarily recalling in total 47 bottles of Spironolactone tablets to the consumer level.
read more
Wednesday, November 06, 2019
C2 PHARMA continues to build its active pharmaceutical ingredient (API) and botanical extracts product portfolio.
read more
Wednesday, October 19, 2022
C2 PHARMA, a pharmaceutical group focused on manufacturing and supplying ophthalmic and niche active pharmaceutical ingredients (APIs) globally, is expanding the API product portfolio. Tropicamide API is launching with regulatory filings in both ...
read more
Monday, February 09, 2015
Camargo Pharmaceutical Services, a leading drug development organization specializing in the 505(b)(2) approval pathway, will reveal its new brand at the Generic Pharmaceutical Association (GPhA) Annual Meeting. The new brand comes as 505(b)(2) is ...
read more
Tuesday, October 24, 2017
Cambrex announced the completion of an expansion to its large scale production capacity at its Iowa plant.
read more
Cambrex announced that it has completed the construction of a $24 million highly potent API (HPAPI) manufacturing facility at its site in Charles City, IA.
read more
Wednesday, April 13, 2022
Cambrex announced the completion of a $50 million expansion of its large-scale active pharmaceutical ingredient (API) manufacturing capabilities at its Charles City, Iowa facility.
read more
Cambrex announced that it has opened a new 120m2 quality control (QC) laboratory at its site in Paullo, Milan, Italy.
read more